Aclaris Therapeutics Inc (ACRS): RA Capital Management Disposes of 1.1 Million Shares

Page 3 of 8 – SEC Filing

 

CUSIP No. 00461U105					13G
	1.	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Peter Kolchinsky
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)   ¨
		(b)   ¨
	3.	SEC Use Only
	4.	Citizenship or Place of Organization         United States
Number of Shares Beneficially Owned by Each Reporting Person With			5.	Sole Voting Power                         0 shares
			6.	Shared Voting Power              1,530,020 shares
			7.	Sole Dispositive Power                 0 shares
			8.	Shared Dispositive Power       1,530,020 shares
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,530,020 shares
	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)          ¨
	11.	Percent of Class Represented by Amount in Row (9) 7.1%1
	12.	Type of Reporting Person (See Instructions) IN

 

¹
The reporting person is the beneficial owner of 1,530,020 shares of the Issuer’s Common Stock which constitute
approximately 7.1% of the Issuer’s outstanding Common Stock shares. The percentage calculation assumes that there are currently
21,415,397 outstanding shares of Common Stock of the Issuer, based on the Issuer’s Form 10-Q as filed with the Securities
and Exchange Commission (“SEC”) on August 11, 2016.